Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Clinical trial NCT04852081 · UNKNOWN

Trial details

NCT number: NCT04852081
Sponsor: Blokhin's Russian Cancer Research Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Breast Cancer Stage IV

Start date: 2021-01-01
Primary completion: 2021-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.